ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Janus reveals another face: the biologic rationale for targeting Janus kinase 2 in lymphoma.

Ann Mullally et al.PubMed ↗Publisher ↗

No numbers read from the abstract.